Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00080873 · ClinicalTrials.gov registry record · NA
Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
A NA study, sponsored by Children's Oncology Group.
- Completed
- Registry status
- NA
- Development phase
- 195
- Enrollment target
NCT00080873 is a NA study that has completed, run by Children's Oncology Group. The registered enrollment target is 195 participants.
The verdict
NCT00080873, a NA study, has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- NA
- Development phase
- 195 participants
- Enrollment target
Study Summary
RATIONALE: Traumeel® S (a mouth rinse) may be effective in preventing or decreasing the severity of oral mucositis caused by chemotherapy in young patients who are undergoing stem cell transplantation. PURPOSE: This randomized clinical trial is studying how well Traumeel® S works in preventing or treating mucositis in young patients who are receiving chemotherapy with or without total-body irradiation before undergoing stem cell transplantation.
Interventions
- OTHER Placebo
- DRUG Traumeel S
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 195 participants |
| Start Date | 2004-04 |
| Est. Completion | 2011-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00080873
The ClinicalTrials.gov registry entry for NCT00080873 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 195 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Oncology Group, which has 342 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00080873 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00080873 about?
NCT00080873 is a clinical study titled "Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation". RATIONALE: Traumeel® S (a mouth rinse) may be effective in preventing or decreasing the severity of oral mucositis caused by chemotherapy in young patients who are undergoing stem cell transplantation. PURPOSE: This randomized clinical trial is studying how well Traumeel® S works in preventing or t...
What is the current status of trial NCT00080873?
This trial is currently completed. It is a NA study. The enrollment target is 195 participants. The study started on 2004-04. Estimated completion is 2011-01.
What interventions are being tested in trial NCT00080873?
The interventions under investigation include: Placebo (OTHER), Traumeel S (DRUG).
Who is sponsoring clinical trial NCT00080873?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.